Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
NCT03626714
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Organ Transplant Rejection
Psoriasis
Interventions
DRUG:
Sustained Release Injectable Tacrolimus
Sponsor
Auritec Pharmaceuticals
Collaborators
[object Object]